Combination and tricombination therapy to destabilize the structural integrity of COVID-19 by some bioactive compounds with antiviral drugs: insights from molecular docking study
H. R. Abd El-Mageed, Doaa A. Abdelrheem, Shimaa A. Ahmed, Aziz Abdur Rahman, Khaled N. M. Elsayed, Sayed A. Ahmed, Ashraf A. El‐Bassuony, Hussein S. Mohamed, Ashraf A. El‐Bassuony, Hussein S. Mohamed
Topics & Concepts
ChemistryCoronavirus disease 2019 (COVID-19)Docking (animal)Computational biologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCombinatorial chemistryComputational chemistryPharmacologyNanotechnologyVirologyInfectious disease (medical specialty)Materials scienceNursingDiseaseMedicinePathologyBiologyOutbreakDiverse Scientific Research StudiesComputational Drug Discovery MethodsCOVID-19 Clinical Research Studies